Editas Medicine
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell EDIT and other ETFs, options, and stocks.About EDIT
Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9).
EDIT Key Statistics
Stock Snapshot
Editas Medicine(EDIT) stock is priced at $3.20, giving the company a market capitalization of 495.3M. It carries a P/E multiple of -4.34.
On 2026-09-06, Editas Medicine(EDIT) stock moved within a range of $3.04 to $3.23. With shares now at $3.20, the stock is trading +5.3% above its intraday low and -0.9% below the session's peak.
Trading volume for Editas Medicine(EDIT) stock has reached 1.39M, versus its average volume of 2.29M.
The stock's 52-week range extends from a low of $1.66 to a high of $4.54.
The stock's 52-week range extends from a low of $1.66 to a high of $4.54.
Analyst ratings
55%
of 11 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.